The risk of thromboembolic events with early intravenous 2‐ and 4‐g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: A secondary analysis of a randomized, double‐blind, placebo‐controlled, single‐center trial
Philip C. Spinella, Grant V. Bochicchio(University of Maryland, Baltimore), Kelly Bochicchio(Washington University in St. Louis), Amanda M. Staudt(United States Army Institute of Surgical Research), Jerrold H. Levy(Duke University), Anthony E. Pusateri(United States Army Institute of Surgical Research), Kimberly A. Thomas(Washington University in St. Louis), Douglas Schuerer(Washington University in St. Louis), Susan M. Shea(University of Iowa)
Cited by 27
Related Papers
Guidelines for Perioperative Care in Cardiac Surgery
|JAMA Surgery|2019|1.2k
Patient Blood Management
|JAMA|2019|619
Effects of Red-Cell Storage Duration on Patients Undergoing Cardiac Surgery
|New England Journal of Medicine|2015|486
The coagulopathy, endotheliopathy, and vasculitis of COVID-19
|Inflammation Research|2020|437
Derangement of the endothelial glycocalyx in sepsis
|Journal of Thrombosis and Haemostasis|2018|311